Thyroid Hormone as a Prophylactic Agent Following Radical Treatment of Breast Cancer
Author Information
Author(s): A. R. Lyons, G. A. Edelstyn
Primary Institution: Northern Ireland Radiotherapy Centre
Hypothesis
Does thyroid hormone have a prophylactic effect after radical treatment of breast cancer?
Conclusion
The study suggests that thyroid extract and thyroxine have no clinical value as prophylactic agents after breast cancer treatment.
Supporting Evidence
- Patients receiving thyroxine had a higher chance of surviving to the 5th anniversary compared to control groups.
- The incidence of local recurrence was greater among patients receiving hormone therapy.
- Thyroid extract was found to be valueless as a prophylactic agent after mastectomy.
Takeaway
The study looked at whether thyroid hormones help prevent breast cancer from coming back after treatment, and it found that they don't really work.
Methodology
Patients with Stage I or II breast cancer who underwent local mastectomy were divided into test and control groups, with the test group receiving thyroid hormone.
Potential Biases
Selection bias may have occurred based on the year of birth for group assignment.
Limitations
The study had a small number of patients and could not definitively compare results stage for stage.
Participant Demographics
Patients included were those with clinical Stage I or II breast carcinomas.
Want to read the original?
Access the complete publication on the publisher's website